Condition: Ulcerative Colitis (UC) · Sponsor: Innatus Therapeutics (Shanghai) Co., Ltd.
A Multicenter, Randomized, Open-label Clinical Study to Evaluate the Safety and Efficacy of INT-210 Capsules in Participants with Active Ulcerative Colitis. The study aims to evaluate the safety, efficacy, pharmacokinetic (PK) characteristics, pharmacodynamic (PD) characteristics of INT-210 in participants with active ulcerative colitis (UC).
This description comes directly from the study's public registry record.
Iris Liu · +86 010-82089858 · irisliu@innatustherapeutics.com
Always discuss trial participation with your own doctor first.
| The Sixth Affiliated Hospital, Sun Yat-sen University | Guangzhou, Guangdong, China | Recruiting |
| Shengjing Hospital of China Medical University | Shenyang, Liaoning, China | Recruiting |
| Beijing Chao-Yang Hospital, Capital Medical University | Beijing, China | Recruiting |
| Beijing Friendship Hospital, Capital Medical University | Beijing, China | Recruiting |
| Beijing Luhe Hospital, Capital Medical University | Beijing, China | Recruiting |
| Guangzhou First People's Hospital | Guangzhou, China | Recruiting |
| The First Affiliated Hospital, Sun Yat-sen University | Guangzhou, China | Recruiting |
| The First Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou, China | Recruiting |
| XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine | Shanghai, China | Recruiting |
| Shanxi Bethune Hospital | Taiyuan, China | Recruiting |
| Weifang People's Hospital | Weifang, China | Recruiting |
| The Second Affiliated Hospital of Wenzhou Medical University | Wenzhou, China | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07692165